Last Update 17:49
Friday, 10 July 2020

Trump: FDA authorizes Remdesivir drug for COVID-19

Reuters , Friday 1 May 2020
Share/Bookmark
Views: 1578
Share/Bookmark
Views: 1578

President Donald Trump said on Friday the U.S. Food and Drug Administration (FDA) had granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug Remdesivir to treat patients with COVID-19.

During a meeting in the Oval Office with the president, Gilead Chief Executive Daniel O'Day called the move an important first step and said the company was donating 1 million vials of the drug to help patients.

Short link:

 

Latest

© 2010 Ahram Online.